Physician profile
Ashika Sheth
NPI 1730321852
$1,002.64
in general payments reported to CMS, 2019-2025
18 companies · $231 in 2025
The $231 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $242 · 2022: $386 · 2023: $56.31 · 2024: $87.01 · 2025: $231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $374.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $153.21 | 2021-2025 | Xifaxan, Relistor |
| Abbott Laboratories | $131.04 | 2021-2022 | |
| Medtronic, INC. | $123.10 | 2022 | |
| Relievant Medsystems, INC. | $106.67 | 2022 | |
| Boston Scientific Corporation | $106.53 | 2023-2025 | General - Pain Management |
| Collegium Pharmaceutical, INC. | $87.85 | 2021-2025 | Belbuca, Xtampza |
| Forte Bio-Pharma LLC | $68.11 | 2022-2024 | Prolate, Nalocet |
| Redhill Biopharma INC. | $31.44 | 2021-2022 | |
| Averitas Pharma INC. | $29.98 | 2025 | Qutenza |
| Tersera Therapeutics LLC | $25.12 | 2021 | |
| Bioventus LLC | $24.96 | 2022 | |
| Curonix LLC | $23.54 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Amgen INC. | $21.35 | 2021 | |
| Vbi Vaccine (Delaware) INC. | $19.67 | 2023 | Prehevbrio |
| International Rehabilitative Sciences, INC | $13.76 | 2023 | Rs 4i Plus Sequential Stimulator |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $12.47 | 2021 | |
| Nevro Corp. | $12.07 | 2022 | |
| Arbor Pharmaceuticals, INC. | $11.77 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashika Sheth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.